Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Baxter International Inc. BAX

Healthcare  —  Medical Instruments & Supplies
23.37 (0.11) (0.47%) as of 25 Sep
Market cap
$12.2B
P/E
0.0×
S&P 500 Member Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Baxter International Inc. (BAX) EV/EBITDA

As of 25 September 2026, Baxter International Inc. (BAX) trades at a EV/EBITDA of 13.3×. Over the past ten years it has ranged from 10.2× (March 2015) to 45.0× (December 2023); the current reading is higher than 9% of that period. That is below the Medical Instruments & Supplies industry median of 16.1× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 12.0× (32.27%)
FY2024 17.7× (1.59%)
FY2023 17.9× (38.95%)
FY2022 29.4× 12.72%
FY2021 26.1× 47.87%
FY2020 17.6× 2.52%
FY2019 17.2× 10.07%
FY2018 15.6× (12.98%)
FY2017 18.0× 14.41%
FY2016 15.7× (5.28%)

Quarterly

Period EV/EBITDA Change
Jun 2026 12.6× 13.25%
Mar 2026 11.1× (6.89%)
Dec 2025 12.0× (11.18%)
Sep 2025 13.5× (16.57%)
42 more quarters

Against its own ten years

Low 10.2× High 45.0×
Ten-year median 17.7×
Current reading's percentile 9

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation compare 7.9×
ATR AptarGroup, Inc. compare 11.5×
ALGN Align Technology, Inc. compare 11.7×
BAX Baxter International Inc. 13.3×
COO The Cooper Companies, Inc. compare 14.1×
BLCO Bausch + Lomb Corporation compare 14.4×
STVN Stevanato Group S.p.A. compare 18.1×
RGEN Repligen Corporation compare 65.3×
AVTR Avantor, Inc. compare 110×
Medical Instruments & Supplies industry median 16.1×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BAX